Skip to main content

Advertisement

Log in

Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Although it is generally believed that nicotine accounts for the beneficial effect of smoking on ulcerative colitis, the underlying mechanisms remain not well understood. Our previous finding that nicotine inhibits inflammatory responses through inducing miR-124 prompted us to ask whether the miRNA is involved in the protective action of nicotine against UC. Our present study found that miR-124 expression is upregulated in colon tissues from UC patients and DSS colitis mice. Nicotine treatment further augmented miR-124 expression in lymphocytes isolated from human ulcerative colonic mucosa and ulcerative colon tissues from DSS mice, both in infiltrated lymphocytes and epithelial cells. Moreover, knockdown of miR-124 significantly diminished the beneficial effect of nicotine on murine colitis and IL-6-treated Caco-2 colon epithelial cells. Further analysis indicated that nicotine inhibited STAT3 activation in vivo and in IL-6 treated Caco-2 cells and Jurkat human T lymphocytes, in which miR-124 knockdown led to increased activation of STAT3. Blocking STAT3 activity alone is beneficial for DSS colitis and also abolished nicotine’s protective effect in this model. These data indicate that nicotine exerts its protective action in UC through inducing miR-124 and inhibiting STAT3, and suggest that the miR-124/STAT3 system is a potential target for the therapeutic intervention of UC.

Key message

  • Nicotine upregulates miR-124 expression in ulcerative colon tissues and cells.

  • MiR-124 is required for the protective role of nicotine in DSS colitis mice and epithelial cells.

  • The protective effect of nicotine in murine DSS colitis depends on blocking STAT3 activation.

  • MiR-124 mediates the inhibitory role of nicotine on STAT3/p-STAT3.

  • Targeting miR-124 and STAT3 represents a novel approach for treating ulcerative colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Seidelin JB, Coskun M, Vainer B, Riis L, Soendergaard C, Nielsen OH (2013) ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis. J Mol Med 91:839–849

    Article  CAS  PubMed  Google Scholar 

  2. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ (2012) Ulcerative colitis. Lancet 380:1606–1619

    Article  PubMed  Google Scholar 

  3. Shanahan F (1993) Pathogenesis of ulcerative colitis. Lancet 342:407–411

    Article  CAS  PubMed  Google Scholar 

  4. Ford AC, Moayyedi P, Hanauer SB (2013) Ulcerative colitis. BMJ 346:f432

    Article  PubMed  Google Scholar 

  5. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, et al. (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60:571–607

    Article  PubMed  Google Scholar 

  6. Harries AD, Baird A, Rhodes J (1982) Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 284:706

    Article  CAS  Google Scholar 

  7. Boyko EJ, Koepsell TD, Perera DR, Inui TS (1987) Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 316:707–710

    Article  CAS  PubMed  Google Scholar 

  8. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S (2006) Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 81:1462–1471

    Article  PubMed  Google Scholar 

  9. Lunney PC, Leong RW (2012) Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 36:997–1008

    Article  CAS  PubMed  Google Scholar 

  10. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, Newcombe RG, Russell MA, Feyerabend C, Thomas GA, et al. (1994) Transdermal nicotine for active ulcerative colitis. N Engl J Med 330:811–815

    Article  CAS  PubMed  Google Scholar 

  11. Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Petersen BT, Batts KP, Croghan IT, Dale LC, Schroeder DR, Hurt RD (1997) Transdermal nicotine for mildly to moderately active ulcerative colitis. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 126:364–371

    Article  CAS  PubMed  Google Scholar 

  12. Benowitz NL (2010) Nicotine addiction. N Engl J Med 362:2295–2303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Garrett WS, Gordon JI, Glimcher LH (2010) Homeostasis and inflammation in the intestine. Cell 140:859–870

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258–J265

    Article  CAS  PubMed  Google Scholar 

  15. Sun Y, Li Q, Gui H, DP X, Yang YL, DF S, Liu X (2013) MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res 23:1270–1283

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ (2012) New insights into the role of STAT3 in IBD. Inflamm Bowel Dis 18:1177–1183

    Article  PubMed  Google Scholar 

  17. Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ (2010) Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 59:227–235

    Article  PubMed  Google Scholar 

  18. Hayashi S, Hamada T, Zaidi SF, Oshiro M, Lee J, Yamamoto T, Ishii Y, Sasahara M, Kadowaki M (2014) Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice. Am J Physiol Gastrointest Liver Physiol 307:G968–G978

    Article  CAS  PubMed  Google Scholar 

  19. Wirtz S, Neufert C, Weigmann B, Neurath MF (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2:541–546

    Article  CAS  PubMed  Google Scholar 

  20. AlSharari SD, Akbarali HI, Abdullah RA, Shahab O, Auttachoat W, Ferreira GA, White KL, Lichtman AH, Cabral GA, Damaj MI (2013) Novel insights on the effect of nicotine in a murine colitis model. J Pharmacol Exp Ther 344:207–217

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Atreya R, Neurath MF (2005) Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 28:187–196

    Article  CAS  PubMed  Google Scholar 

  22. Schust J, Sperl B, Hollis A, Mayer TU, Berg T (2006) Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 13:1235–1242

    Article  CAS  PubMed  Google Scholar 

  23. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL (2011) MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-[alpha]-PU. 1 pathway. Nat Med 17:64–70

    Article  CAS  PubMed  Google Scholar 

  24. Cheng LC, Pastrana E, Tavazoie M, Doetsch F (2009) miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 12:399–408

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Willemen HL, Huo XJ, Mao-Ying QL, Zijlstra J, Heijnen CJ, Kavelaars A (2012) MicroRNA-124 as a novel treatment for persistent hyperalgesia. J Neuroinflammation 9:143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Veremeyko T, Siddiqui S, Sotnikov I, Yung A, Ponomarev ED (2013) IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PLoS One 8:e81774

    Article  PubMed  PubMed Central  Google Scholar 

  27. Wang JY, Mao RC, Zhang YM, Zhang YJ, Liu HY, Qin YL, Lu MJ, Zhang JM (2015) Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection. J Viral Hepat 22:128–136

    Article  CAS  PubMed  Google Scholar 

  28. Xia Y, Chen K, Zhang MH, Wang LC, Ma CY, Lin YL, Zhao YR (2015) MicroRNA-124 involves in ankylosing spondylitis by targeting ANTXR2. Mod Rheumatol 25:784–789

    Article  PubMed  Google Scholar 

  29. Mendell JT, Olson EN (2012) Micrornas in stress signaling and human disease. Cell 148:1172–1187

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Koukos G, Polytarchou C, Kaplan JL, Morley-Fletcher A, Gras-Miralles B, Kokkotou E, Baril-Dore M, Pothoulakis C, Winter HS, Iliopoulos D (2013) MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 145:842–852.e2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Zhao Y, Ma T, Chen W, Chen Y, Li M, Ren L, Chen J, Cao R, Feng Y, Zhang H, et al. (2016) MicroRNA-124 promotes intestinal inflammation by targeting aryl hydrocarbon receptor in Crohn’s disease. J Crohns Colitis 10:703–712

    Article  PubMed  Google Scholar 

  32. Lakatos PL, Szamosi T, Lakatos L (2007) Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 13:6134–6139

    Article  PubMed  PubMed Central  Google Scholar 

  33. Rufo PA, Bousvaros A (2007) Challenges and progress in pediatric inflammatory bowel disease. Curr Opin Gastroenterol 23:406–412

    Article  PubMed  Google Scholar 

  34. Wang D, Zhang H, Li M, Frid MG, Flockton AR, McKeon BA, Yeager ME, Fini MA, Morrell NW, Pullamsetti SS, et al. (2014) MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res 114:67–78

    Article  CAS  PubMed  Google Scholar 

  35. Kawano S, Nakamachi Y (2011) miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis. Ann Rheum Dis 70(suppl 1):i88–i91

    Article  CAS  PubMed  Google Scholar 

  36. Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, Lehr HA, Schmidt J, Neurath MF (2005) Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol 100:64–72

    Article  CAS  PubMed  Google Scholar 

  37. Fu XY (2006) STAT3 in immune responses and inflammatory bowel diseases. Cell Res 16:214–219

    Article  CAS  PubMed  Google Scholar 

  38. Musso A, Dentelli P, Carlino A, Chiusa L, Repici A, Sturm A, Fiocchi C, Rizzetto M, Pegoraro L, Sategna-Guidetti C, et al. (2005) Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflamm Bowel Dis 11:91–98

    Article  PubMed  Google Scholar 

  39. Bai A, Hu P, Chen J, Song X, Chen W, Peng W, Zeng Z, Gao X (2007) Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis. Int J Color Dis 22:625–635

    Article  Google Scholar 

  40. Mitsuyama K, Matsumoto S, Rose-John S, Suzuki A, Hara T, Tomiyasu N, Handa K, Tsuruta O, Funabashi H, Scheller J, et al. (2006) STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Gut 55:1263–1269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Lee MJ, Lee JK, Choi JW, Lee CS, Sim JH, Cho CH, Lee KH, Cho IH, Chung MH, Kim HR, et al. (2012) Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS One 7:e38801

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Nguyen AV, Wu YY, Liu Q, Wang D, Nguyen S, Loh R, Pang J, Friedman K, Orlofsky A, Augenlicht L, et al. (2013) STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon. Neoplasia 15:998–1008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Neufert C, Pickert G, Zheng Y, Wittkopf N, Warntjen M, Nikolaev A, Ouyang W, Neurath MF, Becker C (2010) Activation of epithelial stat3 regulates intestinal homeostasis. Cell Cycle 9:652–655

    Article  CAS  PubMed  Google Scholar 

  44. Uddin MJ, Jeong SO, Zheng M, Chen Y, Cho GJ, Chung HT, Joe Y (2013) Carbon monoxide attenuates dextran sulfate sodium-induced colitis via inhibition of GSK-3β signaling. Oxidative Med Cell Longev 2013:210563

    Article  Google Scholar 

  45. Thomas GA, Rhodes J, Mani V, Williams GT, Newcombe RG, Russell MA, Feyerabend C (1995) Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 332:988–992

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Xiu-Ming Guo (Department of Pharmacology, Second Military Medical University, China) and Can-Rong Ni (Changhai Hospital, Second Military Medical University, China) for their assistance in IHC and ISH and their help in evaluating HE tissue sections. This study was supported by the grants from the National Natural Science Foundation of China (81273606 and 81473259 to XL, 81230083 to DFS, 81570474 to PD and 81603116 to YS), and National Science and Technology Major Project (2014ZX09J14103-08C to XL).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ding-Feng Su, Yili Yang or Xia Liu.

Ethics declarations

All animal experiments were undertaken with the approval of the Scientific Investigation Board of the Second Military Medical University. The study protocol was approved by the ethics committee of Shanghai Jiaotong University, and all subjects provided informed consent

Competing interests

The authors declare that they have no competing interests.

Additional information

This article has been presented as a poster at Annual Meeting of the American Association of Immunology held in New Orleans, USA on May 8–12, 2015 and was included in the conference proceedings as a meeting abstract.

Zhen Qin and Jing-Jing Wan contributed equally to this work

Electronic supplementary material

ESM 1

(DOC 1578 kb)

ESM 2

(DOC 753 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qin, Z., Wan, JJ., Sun, Y. et al. Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3. J Mol Med 95, 221–233 (2017). https://doi.org/10.1007/s00109-016-1473-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-016-1473-5

Keywords

Navigation